725.50
+2.76%
Close of 9 Nov 2026, in DKK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Chemometec A/S
Its shares trade on Nasdaq Copenhagen under the ticker CHEMM.CO. It has been listed since 18 December 2006. In the fiscal year to 30 June 2026, it reported revenue of DKK 511.1m and net income of DKK 201.8m. At that date it held total assets of DKK 860.9m and shareholders' equity of DKK 725.4m.
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 18 Dec 2006
- Employees
- 121
- Website
- chemometec.com ↗
Leadership
Pay as last reported
- Mr. Niels ThestrupChairman of the Board, since 2021DKK 800,000
- Mr. Martin BehrensChief Executive OfficerDKK 6.4m
- Mr. Martin GlensbjergVice Chairman of the Board, since 2001DKK 360,000
- Mr. Kim NicolajsenChief Financial OfficerDKK 3.1m
- Ms. Kristine FaerchIndependent DirectorDKK 300,000
- Ms. Betina HagerupIndependent DirectorDKK 340,000
- Mr. Peter ReichIndependent DirectorDKK 280,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 30
- Environment
- 26
- Social
- 57
- Governance
- 7
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Chemometec A/S has a strong reputation in the market for their innovative products and technologies.
- The company has a highly skilled and knowledgeable workforce, which enables them to develop and deliver high-quality solutions.
- Chemometec A/S has a wide range of product offerings, catering to various industries and customer needs.
Weaknesses
- One weakness of Chemometec A/S is their reliance on a limited number of suppliers, which could result in supply chain disruptions.
- The company may face challenges in scaling their production capacity to meet increasing market demand.
- Chemometec A/S lacks strong brand recognition compared to some of their competitors.
Opportunities
- There is a growing demand for advanced technologies in the healthcare sector, which presents an opportunity for Chemometec A/S to expand their market share.
- The company can explore strategic partnerships and collaborations to leverage their expertise and access new markets.
- Chemometec A/S can invest in research and development to continually innovate and develop new products that meet emerging customer needs.
Threats
- Intense competition in the industry poses a threat to Chemometec A/S, as competitors may offer similar products at lower prices.
- Evolving regulations and compliance requirements could impact the company's operations and increase costs.
- Changes in market trends and customer preferences may require Chemometec A/S to adapt quickly in order to remain competitive.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.